Search Results - "Lafoux, A"

Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy by Rocheteau, P., Chatre, L., Briand, D., Mebarki, M., Jouvion, G., Bardon, J., Crochemore, C., Serrani, P., Lecci, P. P., Latil, M., Matot, B., Carlier, P. G., Latronico, N., Huchet, C., Lafoux, A., Sharshar, T., Ricchetti, M., Chrétien, F.

“…Sepsis, or systemic inflammatory response syndrome, is the major cause of critical illness resulting in admission to intensive care units. Sepsis is caused by…”
Get full text

Effects of oral administration of rotenone on gastrointestinal functions in mice by Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., Huchet‐Cadiou, C., Aubert, P., Hunot, S., Derkinderen, P., Neunlist, M.

“…Background  The systemic rotenone model of Parkinson’s disease (PD) accurately replicates many aspects of the pathology of human PD, especially…”
Get full text

T.P.2.02 Effect of 20 approved drugs on a wide range of mdx parameters by Carre-Pierrat, M, Lafoux, A, Fougerousse, F, Huchet-Cadiou, C, Ségalat, L

Get full text

Adenosine reduces the reverse mode of the Na+/Ca(2+) exchanger in ferret cardiac fibres by Hleihel, W, Lafoux, A, Ouaini, N, Huchet-Cadiou, C

“…The aim of this study was to investigate the effects of adenosine on reverse mode Na+/Ca(2+) exchange. In intact ferret cardiac trabeculae, Na+-free…”
Get more information

Adenosine affects the release of Ca2+ from the sarcoplasmic reticulum via A2A receptors in ferret skinned cardiac fibres by Hleihel, W., Lafoux, A., Ouaini, N., Divet, A., Huchet‐Cadiou, C.

“…In this study, it was shown that adenosine potentiates caffeine-induced Ca 2+ release. It was then proposed that the enhancement of the caffeine-induced Ca 2+…”
Get full text

Acceleration of heavy clusters to MeV energies at the Orsay MP tandem by Waast, B, Della-Negra, S, Lafoux, A

“…Beams of heavy cluster ions have been routinely accelerated by the Orsay MP tandem for the past two years. One can operate the accelerator in the tandem mode,…”
Get full text

DMD – ANIMAL MODELS by Creisméas, A., Gazaille, C., Bourdon, A., Lafoux, A., Allais, M., Razavet, V. Le, Ledevin, M., Larcher, T., Toumanianz, G., Anegon, I., Adjali, O., Huchet, C., Guiner, C. Le, Fraysse, B.

Get full text

DMD – ANIMAL MODELS: EP.89 TRPC1 and TRPC3 involvement in DMD physiopathology and as potential targets for treatment in complement to rAAV-microdystrophin by Creisméas, A., Gazaille, C., Bourdon, A., Lafoux, A., Allais, M., Razavet, V. Le, Ledevin, M., Larcher, T., Toumanianz, G., Anegon, I., Adjali, O., Huchet, C., Guiner, C. Le, Fraysse, B.

Get full text

DMD TREATMENT: ANIMAL MODELS by Le Guiner, C., Moullier, P., McIntyre, M., Larcher, T., Adjali, O., LaFoux, A., Toumaniantz, G., Owens, J., Xiao, X., Binks, M., LaRosa, G., Samulski, R.

Get full text

DMD TREATMENT: ANIMAL MODELS: P.200Assessment of efficacy of a rAAV9-mini-dystrophin gene therapy candidate (PF-06939926) administered to aged DMDmdx rats by Le Guiner, C., Moullier, P., McIntyre, M., Larcher, T., Adjali, O., LaFoux, A., Toumaniantz, G., Owens, J., Xiao, X., Binks, M., LaRosa, G., Samulski, R.

Get full text

Dose finding study in the DMDmdx rat model to determine the efficacious dose of a rAAV9 vector encoding a human mini-dystrophin after IV administration by Guiner, C. Le, McIntyre, M., Larcher, T., Adjali, O., Lafoux, A., Toumaniantz, G., Wood, L., Xiao, X., Moullier, P., Samulski, R.

Get full text

TH.O.20 - Exhaustive characterization of the newly developed Duchenne muscular dystrophy rat model: a unique animal model for DMD which mimics the human disease at both the muscular and the cardiac levels by Huchet, C., Toumaniantz, G., Larcher, T., Fraysse, B., Lafoux, A., Remy, S., Caudal, D., Allais, M., Amosse, E., Anegon, I., Guiner, C. Le

Get full text

P.304 - Dose finding study in the DMDmdx rat model to determine the efficacious dose of a rAAV9 vector encoding a human mini-dystrophin after IV administration by Guiner, C. Le, McIntyre, M., Larcher, T., Adjali, O., Lafoux, A., Toumaniantz, G., Wood, L., Xiao, X., Moullier, P., Samulski, R.

Get full text

Extensive Characterization of the Newly Developed Dmd mdx Rat Model: A Unique Animal Model for Duchene Muscular Dystrophy by Larcher, T., Huchet, C., Toumaniantz, G., Fraysse, B., Lafoux, A., Remy, S., Caudal, D., Allais, M., Amosse, E., Anegon, I., Le Guiner, C.

Get full text

Extensive Characterization of the Newly Developed Dmdmdx Rat Model: A Unique Animal Model for Duchene Muscular Dystrophy by Larcher, T., Huchet, C., Toumaniantz, G., Fraysse, B., Lafoux, A., Remy, S., Caudal, D., Allais, M., Amosse, E., Anegon, I., Le Guiner, C.

Get full text

Exhaustive characterization of the newly developed Duchenne muscular dystrophy rat model: a unique animal model for DMD which mimics the human disease at both the muscular and the cardiac levels by Huchet, C., Toumaniantz, G., Larcher, T., Fraysse, B., Lafoux, A., Remy, S., Caudal, D., Allais, M., Amosse, E., Anegon, I., Guiner, C. Le

Get full text

Nuclear targets, recoil ion catchers and reaction chambers by Dionisio, J.S., Vieu, Ch, Schück, C., Collatz, R., Meunier, R., Ledu, D., Folger, H., Lafoux, A., Lagrange, J.M., Pautrat, M., Waast, B., Phillips, W.R., Blunt, D., Durell, J.L., Varley, B.J., Dagnall, P.G., Dorning, S.J., Jones, M.A., Smith, A.G., Bacelar, J.C.S., Urban, W., Rzaca-Urban, T., Amzal, N., Méliani, Z., Vanhorenbeeck, J., Passoja, A.

“…The main features of nuclear targets, recoil ion catchers and reaction chambers used in nuclear spectroscopic investigations involving in-beam multi-e- γ…”
Get full text

Accelerated ion beams for in-beam e- γ spectroscopy by Dionisio, J.S, Vieu, Ch, Schück, C, Meunier, R, Ledu, D, Lafoux, A, Lagrange, J.M, Pautrat, M, Waast, B, Phillips, W.R, Varley, B.J, Durell, J.L, Dagnall, P.G, Dorning, S.J, Jones, M.A, Smith, A.G, Bacelar, J.C.S, Urban, W, Rzaca-Urban, T, Folger, H, Vanhorenbeeck, J

“…A few accelerated ion beam requirements for in-beam e- γ spectroscopy are briefly reviewed as well as several features of the MP Tandem accelerator of…”
Get full text

Aspect fonctionnel du vieillissement musculaire : évaluation de la force et des caractéristiques de la marche chez le rat âgé sarcopénique by Lafoux, A., Le Ruyet, P., Huchet, C.

“…La sarcopénie est à l’origine d’une détérioration générale de l’état physique se traduisant par une perte de masse et de force musculaire conduisant à des…”
Get full text

Pre-clinical study of 21 approved drugs in the mdx mouse by Carre-Pierrat, Maïté, Lafoux, Aude, Tanniou, Guillaume, Chambonnier, Lucie, Divet, Alexandra, Fougerousse, Francoise, Huchet-Cadiou, Corinne, Ségalat, Laurent

“…Abstract Duchenne muscular dystrophy, a genetic disease caused by the absence of functional dystrophin, remains without adequate treatment. Although great…”
Get full text